Mass Spectra of Designer Drugs 2015, CD-ROM

Compounds classifed as "Designer Drugs" have been synthesized for several decades. This is not a precise scientific term and should only be applied to those drugs that are synthesized from common chemicals and skillfully marketed under attractive, exotic names, often to skirt existing laws.

Because many designer drugs are novel or designed to evade detection, they can be overlooked or difficult to detect or characterize. The last two decades have seen a proliferation of such substances, such that keeping abreast of this huge numnber of new drugs is a difficult task for forensic chemists and toxicologists. Compiled by a team originating from the Regional Departments of Crmininal Investigation in Keil, Hamburg, and Weisbaden Germany,Mass Spectra of Designer Drugs has been developed to help foresnics and toxicology labs combat this global health epidemic.

Updated annually, the 2015 edition of Mass Spectra of Designer Drugs covers the entire range of known designer drugs through December 31, 2014. Upgrades are available for purchasers of prior editions. Contact your sales person for upgrade information.

Specifications Mass spectra: 21,013 Structures: 21,013 TSQ spectra: 9,405 GCQ spectra: 1,109 CI spectra: 554 HP spectra: 1,395 Trace spectra: 1,193 GC/MS spectra: 20,831 Direct insert spectra: 181 Total compounds: 16,877 CAS RN: 6,531 Kovat's indices: 12,728 Indications noted: 21,013 Verified MS: 2,229 Orthogonally validated MS: 5,498 Average peaks/spectrum: 174.3 Average Quality Index: 943 Replicate Spectra: 698 Compound Coverage

Compound Coverage can be verified at